The Oncosearch | Oncotarget

FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition Research Paper

Min Ye, Wei Huang, Wen-wei Wu, Yang Liu, Sheng-nan Ye, Jian-hua Xu

Published Feb 1, 2017 · Vol. 8, No. 9 · pp. 15364-15376

EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics Research Paper

Itaru Yamamoto, Katsuhiko Nosho, Shinichi Kanno, Hisayoshi Igarashi, Hiroyoshi Kurihara, Keisuke Ishigami, Kazuya Ishiguro, Kei Mitsuhashi, Reo Maruyama, Hideyuki Koide, Hiroyuki Okuda, Tadashi Hasegawa, Yasutaka Sukawa, Kenji Okita, Ichiro Takemasa, Hiroyuki Yamamoto, Yasuhisa Shinomura, Hiroshi Nakase

Published Jan 27, 2017 · Vol. 8, No. 11 · pp. 17810-17818

The complicated role of venous drainage on the survival of arterialized venous flaps Research Paper

Weidong Weng, Feng Zhang, Bin Zhao, Zhipeng Wu, Weiyang Gao, Zhijie Li, Hede Yan

Published Jan 27, 2017 · Vol. 8, No. 10 · pp. 16414-16420

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study Clinical Research Papers

Claudia Bighin, Beatrice Dozin, Francesca Poggio, Marcello Ceppi, Paolo Bruzzi, Alessia Dâ€™Alonzo, Alessia Levaggi, Sara Giraudi, Matteo Lambertini, Loredana Miglietta, Marina Vaglica, Vincenzo Fontana, Giuseppina Iacono, Paolo Pronzato, Lucia Del Mastro

Published Jan 18, 2017 · Vol. 8, No. 27 · pp. 44800-44810

Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China Research Paper

Yongchun Zhou, Yanlong Yang, Chenggang Yang, Yunlan Chen, Changshao Yang, Yaxi Du, Guangqiang Zhao, Yinjin Guo, Lianhua Ye, Yunchao Huang

Published Jan 17, 2017 · Vol. 8, No. 9 · pp. 15023-15033

Incidence and risk of infections associated with EGFR-TKIs in advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled trials Review

Yingtian Wang, Mingzhen Wang, Qiaoxia Wang, Zhiying Geng, Mingxiang Sun

Published Jan 17, 2017 · Vol. 8, No. 17 · pp. 29406-29415

Liquid biopsy genotyping in lung cancer: ready for clinical utility? Review

Wei-Lun Huang, Yi-Lin Chen, Szu-Chun Yang, Chung-Liang Ho, Fang Wei, David T. Wong, Wu-Chou Su, Chien-Chung Lin

Published Jan 12, 2017 · Vol. 8, No. 11 · pp. 18590-18608

Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer Research Paper

Lei Zhong, Jiao Yang, Zhixing Cao, Xin Chen, Yiguo Hu, Linli Li, Shengyong Yang

Published Jan 11, 2017 · Vol. 8, No. 8 · pp. 12843-12854

Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC) Research Paper

Qianqian Zhu, Yanan Sun, Yingying Cui, Ke Ye, Chengliang Yang, Daoke Yang, Jie Ma, Xiao Liu, Jinming Yu, Hong Ge

Published Jan 5, 2017 · Vol. 8, No. 8 · pp. 13304-13311

Estimation of cell-free circulating EGFR mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIs Research Paper

Yan-juan Zhu, Hai-bo Zhang, Yi-hong Liu, Fu-li Zhang, Ya-zhen Zhu, Yong Li, Jian-ping Bai, Li-rong Liu, Yan-chun Qu, Xin Qu, Xian Chen, Yan Li, Guang-juan Zheng

Published Jan 4, 2017 · Vol. 8, No. 8 · pp. 13195-13205

Transformation to small-cell carcinoma as an acquired resistance mechanism to AZD9291: A case report Case Report

Lin Li, Hui Wang, Chao Li, Zheng Wang, Ping Zhang, Xu Yan

Published Jan 4, 2017 · Vol. 8, No. 11 · pp. 18609-18614

Genomic mutation-driven metastatic breast cancer therapy: a single center experience Research Paper

Yuan Yuan, Susan E. Yost, John Yim, Yate-Ching Yuan, Nicola M. Solomon, Isa Mambetsariev, Sumanta Pal, Paul Frankel, Ravi Salgia, Susan L. Neuhausen, Joanne Mortimer

Published Jan 3, 2017 · Vol. 8, No. 16 · pp. 26414-26423

Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer Research Paper

Alessandro Russo, Tindara Franchina, Giuseppina Rosaria Rita Ricciardi, Caterina Fanizza, Antonino Scimone, Giuseppe Chiofalo, Antonio Giordano, Vincenzo Adamo

Published Jan 2, 2017 · Vol. 8, No. 5 · pp. 8717-8725

Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-Î²RII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker Clinical Research Papers

Hiroshi Yokouchi, Hiroshi Nishihara, Toshiyuki Harada, Takashi Ishida, Shigeo Yamazaki, Hajime Kikuchi, Satoshi Oizumi, Hidetaka Uramoto, Fumihiro Tanaka, Masao Harada, Kenji Akie, Fumiko Sugaya, Yuka Fujita, Kei Takamura, Tetsuya Kojima, Mitsunori Higuchi, Osamu Honjo, Yoshinori Minami, Naomi Watanabe, Aya Goto, Hiroyuki Suzuki, Hirotoshi Dosaka-Akita, Hiroshi Isobe, Masaharu Nishimura, Mitsuru Munakata

Published Dec 31, 2016 · Vol. 8, No. 24 · pp. 39711-39726

Total DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCR Research Paper

Yu Zhang, Yan Xu, Wei Zhong, Jing Zhao, Minjiang Chen, Li Zhang, Longyun Li, Mengzhao Wang

Published Dec 30, 2016 · Vol. 8, No. 4 · pp. 5861-5873

The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo Research Paper

Shintaro Fujihara, Asahiro Morishita, Kana Ogawa, Tomoko Tadokoro, Taiga Chiyo, Kiyohito Kato, Hideki Kobara, Hirohito Mori, Hisakazu Iwama, Tsutomu Masaki

Published Dec 28, 2016 · Vol. 8, No. 5 · pp. 8536-8549

Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism Research Paper

Yi-Yong Baek, Dong-Keon Lee, Joohwan Kim, Ji-Hee Kim, Wonjin Park, Taesam Kim, Sanghwa Han, Dooil Jeoung, Ji Chang You, Hansoo Lee, Moo-Ho Won, Kwon-Soo Ha, Young-Guen Kwon, Young-Myeong Kim

Published Dec 28, 2016 · Vol. 8, No. 7 · pp. 11763-11777

Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer Research Paper

Nina Kozlova, Marieke Wottawa, DÃ¶rthe Magdalena Katschinski, Glen Kristiansen, Thomas Kietzmann

Published Dec 27, 2016 · Vol. 8, No. 6 · pp. 9885-9898

MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase Research Paper

Recep Bayraktar, Martin Pichler, Pinar Kanlikilicer, Cristina Ivan, Emine Bayraktar, Nermin Kahraman, Burcu Aslan, Serpil Oguztuzun, Mustafa Ulasli, Ahmet Arslan, George Calin, Gabriel Lopez-Berestein, Bulent Ozpolat

Published Dec 27, 2016 · Vol. 8, No. 7 · pp. 11641-11658

The Hippo signaling pathway provides novel anti-cancer drug targets Review

June Sung Bae, Sun Mi Kim, Ho Lee

Published Dec 27, 2016 · Vol. 8, No. 9 · pp. 16084-16098

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition Research Paper

EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics Research Paper

The complicated role of venous drainage on the survival of arterialized venous flaps Research Paper

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study Clinical Research Papers

Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China Research Paper

Incidence and risk of infections associated with EGFR-TKIs in advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled trials Review

Liquid biopsy genotyping in lung cancer: ready for clinical utility? Review

Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer Research Paper

Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC) Research Paper

Estimation of cell-free circulating EGFR mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIs Research Paper

Transformation to small-cell carcinoma as an acquired resistance mechanism to AZD9291: A case report Case Report

Genomic mutation-driven metastatic breast cancer therapy: a single center experience Research Paper

Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer Research Paper

Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-Î²RII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker Clinical Research Papers

Total DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCR Research Paper

The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo Research Paper

Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism Research Paper

Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer Research Paper

MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase Research Paper

The Hippo signaling pathway provides novel anti-cancer drug targets Review

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition Research Paper

EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics Research Paper

The complicated role of venous drainage on the survival of arterialized venous flaps Research Paper

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study Clinical Research Papers

Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China Research Paper

Incidence and risk of infections associated with EGFR-TKIs in advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled trials Review

Liquid biopsy genotyping in lung cancer: ready for clinical utility? Review

Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer Research Paper

Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC) Research Paper

Estimation of cell-free circulating EGFR mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIs Research Paper

Transformation to small-cell carcinoma as an acquired resistance mechanism to AZD9291: A case report Case Report

Genomic mutation-driven metastatic breast cancer therapy: a single center experience Research Paper

Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer Research Paper

Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-Î²RII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker Clinical Research Papers

Total DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCR Research Paper

The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo Research Paper

Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism Research Paper

Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer Research Paper

MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase Research Paper

The Hippo signaling pathway provides novel anti-cancer drug targets Review